Five-year global investment to fuel R&D and manufacturing expansion, supporting development of new technologies and services designed to improve therapy...
Advancing
Singapore’s rising prevalence of kidney disease highlights the crucial need for efficient solutions to empower patients and care teams. About...
Author: Precedence Research Omlyclo is the first omalizumab biosimilar that Health Canada has approved exclusively for use in Canada. It...
Dr. Manuela Stauss-Grabo joined Fresenius Medical Care in 2013 and has since made significant contributions to the field of clinical...
Trillions of microorganisms that live in the human gut may hold the key to healing some serious or chronic lung...
Reaches Significant Milestone for Clinical Results at Scale, Payer Savings, and Network Growth BOSTON, Aug. 28, 2024 /PRNewswire/ -- Interwell Health,...
